Transcription_NN
factor_NN
binding_NN
sites_NNS
downstream_JJ
of_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
transcription_NN
start_NN
site_NN
are_VBP
important_JJ
for_IN
virus_NN
infectivity_NN
._.

When_WRB
transcriptionally_RB
active_JJ
,_,
the_DT
human_JJ
immunodeficiency_NN
virus_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
promoter_NN
contains_VBZ
a_DT
nucleosome-free_JJ
region_NN
encompassing_VBG
both_CC
the_DT
promoter\/enhancer_NN
region_NN
and_CC
a_DT
large_JJ
region_NN
-LRB-_-LRB-
255_CD
nucleotides_NNS
-LCB-_-LRB-
nt_NN
-RCB-_-RRB-
-RRB-_-RRB-
downstream_JJ
of_IN
the_DT
transcription_NN
start_NN
site_NN
._.

We_PRP
have_VBP
previously_RB
identified_VBN
new_JJ
binding_VBG
sites_NNS
for_IN
transcription_NN
factors_NNS
downstream_JJ
of_IN
the_DT
transcription_NN
start_NN
site_NN
-LRB-_-LRB-
nt_NNS
465_CD
to_TO
720_CD
-RRB-_-RRB-
:_:
three_CD
AP-1_NN
sites_NNS
-LRB-_-LRB-
I_NN
,_,
II_CD
,_,
and_CC
III_CD
-RRB-_-RRB-
,_,
an_DT
AP3-like_JJ
motif_NN
-LRB-_-LRB-
AP3-L_NN
-RRB-_-RRB-
,_,
a_DT
downstream_JJ
binding_NN
factor_NN
-LRB-_-LRB-
DBF_NN
-RRB-_-RRB-
site_NN
,_,
and_CC
juxtaposed_VBN
Sp1_NN
sites_NNS
._.

Here_RB
,_,
we_PRP
show_VBP
that_IN
the_DT
DBF_NN
site_NN
is_VBZ
an_DT
interferon-responsive_VBN
factor_NN
-LRB-_-LRB-
IRF_NN
-RRB-_-RRB-
binding_VBG
site_NN
and_CC
that_IN
the_DT
AP3-L_NN
motif_NN
binds_VBZ
the_DT
T-cell-specific_JJ
factor_NN
NF-AT_NN
._.

Mutations_NNS
that_WDT
abolish_VBP
the_DT
binding_NN
of_IN
each_DT
factor_NN
to_TO
its_PRP$
cognate_JJ
site_NN
are_VBP
introduced_VBN
in_IN
an_DT
infectious_JJ
HIV-1_NN
molecular_JJ
clone_NN
to_TO
study_VB
their_PRP$
effect_NN
on_IN
HIV-1_NN
transcription_NN
and_CC
replication_NN
._.

Individual_JJ
mutation_NN
of_IN
the_DT
DBF_NN
or_CC
AP3-L_NN
site_NN
as_RB
well_RB
as_IN
the_DT
double_JJ
mutation_NN
AP-1_NN
-LRB-_-LRB-
III_CD
-RRB-_-RRB-
\/_:
AP3-L_NN
did_VBD
not_RB
affect_VB
HIV-1_NN
replication_NN
compared_VBN
to_TO
that_DT
of_IN
the_DT
wild-type_JJ
virus_NN
._.

In_IN
contrast_NN
,_,
proviruses_NNS
carrying_VBG
mutations_NNS
in_IN
the_DT
Sp1_NN
sites_NNS
were_VBD
totally_RB
defective_JJ
in_IN
terms_NNS
of_IN
replication_NN
._.

Virus_NN
production_NN
occurred_VBD
with_IN
slightly_RB
delayed_VBN
kinetics_NNS
for_IN
viruses_NNS
containing_VBG
combined_JJ
mutations_NNS
in_IN
the_DT
AP-1_NN
-LRB-_-LRB-
III_CD
-RRB-_-RRB-
,_,
AP3-L_NN
,_,
and_CC
DBF_NN
sites_NNS
and_CC
in_IN
the_DT
AP3-L_NN
and_CC
DBF-sites_NNS
,_,
whereas_IN
viruses_NNS
mutated_VBN
in_IN
the_DT
AP-1_NN
-LRB-_-LRB-
I_NN
,_,
II_CD
,_,
III_CD
-RRB-_-RRB-
and_CC
AP3-L_NN
sites_NNS
and_CC
in_IN
the_DT
AP-1_NN
-LRB-_-LRB-
I_NN
,_,
II_CD
,_,
III_CD
-RRB-_-RRB-
,_,
AP3-L_NN
,_,
and_CC
DBF_NN
sites_NNS
exhibited_VBD
a_DT
severely_RB
defective_JJ
replicative_JJ
phenotype_NN
._.

No_DT
RNA-packaging_JJ
defect_NN
could_MD
be_VB
measured_VBN
for_IN
any_DT
of_IN
the_DT
mutant_JJ
viruses_NNS
as_IN
determined_VBN
by_IN
quantification_NN
of_IN
their_PRP$
HIV_NN
genomic_JJ
RNA_NN
._.

Measurement_NN
of_IN
the_DT
transcriptional_JJ
activity_NN
of_IN
the_DT
HIV-1_NN
promoter_NN
after_IN
transient_JJ
transfection_NN
of_IN
the_DT
HIV-1_NN
provirus_NN
DNA_NN
or_CC
of_IN
long_JJ
terminal_JJ
repeat-luciferase_JJ
constructs_NNS
showed_VBD
a_DT
positive_JJ
correlation_NN
between_IN
the_DT
transcriptional_JJ
and_CC
the_DT
replication_NN
defects_NNS
for_IN
most_JJS
mutants_NNS
._.

